Epidemiology of basal-like breast cancer
By R. Millikan, B. Newman, C. Tse, P. Moorman, K. Conway, L. Dressler, Lisa V. Smith, M. Labbok, J. Geradts, J. Bensen and 6 more. Breast Cancer Research and Treatment, 2008
840 citations recorded by the source corpus.
Subfields: Cancer Research, Dermatology, Oncology
View Paper: https://www.semanticscholar.org/paper/143dfb604919580b9ece486d3b835fe8e3ab79a8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Oncology
Citations in the corpus
- Triple-negative breast cancer--current status and future directions. (2009, background): “Overall, the prevalence of TNBC in large unselected breast cancer patient cohorts is 11%–20% [17, 25, 33], whereas in selected cohorts of patients with advanced BC or patients of African-American ethnicity, TNBC may be diagnosed among as many as 23%–28% of all patients [37, 39, 52].”
- Clinical implications of the intrinsic molecular subtypes of breast cancer. (2015, background): “risk for parity and younger age at first term full-term pregnancy [44].”
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 (2011, background): “These subtypes have different epidemiological risk factors [8, 9], different natural histories [10–12], and different responses to systemic and local therapies [13–17].”
- An overview of triple-negative breast cancer (2016, background): “A higher waist/hip ratio is also associated with an increased risk for developing TNBC [36].”
- Deconstructing the molecular portraits of breast cancer (2010, background): “(Millikan et al., 2008; Carey et al., 2006), survival (Perou et al., 2000; Sorlie et al., 2001; Cheang et al., 2009; Hu et al., 2006), and response to treatment (Prat et al., 2010; Nielsen et al., 2010; Parker et al., 2009b; Hugh et al., 2009; Carey et al., 2007; Rouzier et al., 2005a).”
- American Cancer Society guidelines on nutrition and physical activity for cancer prevention (2002, background): “These factors also differ for hormone receptor-positive and hormone receptor-negative breast cancers.(202,203) An area of growing interest is whether early life exposures, including in utero and during adolescence, may have an important effect on breast cancer risk later in life.”
- Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities (2016, background): “are linked to increased risk for aggressive breast cancer subtypes.(63,68-72) Colon and rectum”
- NEW STRATEGIES FOR TRIPLE NEGATIVE BREAST CANCER – DECIPHERING THE HETEROGENEITY (2014, background): “Patients with TNBC have an increased likelihood of distant recurrence and death compared with women with other types of breast cancer (3), as well as a tendency to develop”
- Triple-negative breast cancer: disease entity or title of convenience? (2010, background): “TNBCs and BLBCs are more frequent in women with abdominal obesity”
- US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. (2014, result): “The higher proportion of advanced stage and high-grade tumors among HR+/HER2+ and HR−/HER2+ case patients also has been reported previously and is consistent with the known aggressiveness of these tumor subtypes compared with HR+/HER2− disease (4,8,13,14).”
- Clinicopathological Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network (2012, neutral): “Yes 1861 (12) 235 (9) 482 (19) 1144 (11)”
- Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011, background): “Although parity and premenopausal obesity are associated with reduced breast cancer risk overall, there is limited data on the association of these factors with reduced risk of CBP cancers (9).”